| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10908098 | Experimental Hematology | 2005 | 9 Pages |
Abstract
The ability of MSC to downregulate T-cell priming, proliferation, and cytokine release is deficient in patients with SAA, persists indefinitely after immunosuppressive therapy, but seems to be restored after BMT. Whether these abnormalities are relevant to the pathogenesis of aplastic anemia remains to be determined.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Andrea Bacigalupo, Marisa Valle, Marina Podestà , Anna Pitto, Elena Zocchi, Antonio De Flora, Sara Pozzi, Silvia Luchetti, Francesco Frassoni, Maria Teresa Van Lint, Giovanna Piaggio,